CCR Milestones - 2020

59 New Employee Invention Reports 49 Issued U.S. Patents 27 New Cooperative Research and Development Agreements (CRADA) 13 of these are Clinical CRADAs 184 Active CRADAs 83 of these are Clinical CRADAs 18 New Clinical Trial Agreements (CTAs) 74 Active CTAs *Numbers are for FY2019. The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. TTC supports technology devel- opment activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices and software, and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner. For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit ( ncitechtransfer@mail.nih.gov ) , or visit t echtransfer.cancer.gov for more information. 245 Open Clinical Trials 50 New Clinical Trials 2,068 New Patients CCR by the Numbers 238 Principal Investigators 24 New Faculty Recruits 8 Newly Tenured Investigators ~300 Staff Scientists/ Staff Clinicians ~500 Technical Lab Staff ~800 Postdoctoral/ Clinical Fellows ~250 Postbaccalaureate/ Predoctoral Students ~500 Summer Students >1,000 Articles in Peer-Reviewed Journals 46 Technology Facilities and Platforms Technology Transfer Activities 103 New Licenses for NCI Technologies 576 Active Licenses 4 FDA Breakthrough Drug Designations 29